Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Early research (Phase 1)Looking for participantsNCT06958679What this trial is testingEvaluation of SYS6005 in Patients With Advanced Malignant TumorWho this might be right forB-cell MalignanciesSolid Tumors CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Early research (Phase 1)Active Not RecruitingNCT05311397What this trial is testingA166 in Patients With Advanced Solid Malignant TumorsWho this might be right forBreast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Early research (Phase 1)Study completedNCT02451553What this trial is testingAfatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary CancerWho this might be right forAdvanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more University of Washington 41
Early research (Phase 1)Ended earlyNCT04099277What this trial is testingLY3435151 in Participants With Solid TumorsWho this might be right forSolid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more Eli Lilly and Company 2
Not applicableNo Longer AvailableNCT01151930What this trial is testingLong-Term Compassionate Use Study for Continued Administration of SCB01A-01Who this might be right forMalignant Solid Tumour SynCore Biotechnology Co., Ltd.
Early research (Phase 1)UnknownNCT05554666What this trial is testingASKG315 in Patients With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors AskGene Pharma, Inc. 56
Early research (Phase 1)Study completedNCT01822522What this trial is testingCabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency VirusWho this might be right forAdvanced Malignant Solid NeoplasmHIV InfectionMetastatic Malignant Solid Neoplasm+2 more National Cancer Institute (NCI) 36
Early research (Phase 1)Looking for participantsNCT06770569What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid TumorsWho this might be right forAdvanced Solid Tumors Shandong Suncadia Medicine Co., Ltd. 100
Early research (Phase 1)Looking for participantsNCT07190469What this trial is testingPQ203 in Advanced Malignant Tumors Including Triple Negative Breast CancerWho this might be right forTriple Negative Breast Cancer (TNBC)Advanced Solid Tumors Cancer ProteinQure Inc. 80
Early research (Phase 1)Looking for participantsNCT06592417What this trial is testingTo Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor Jiangsu Alphamab Biopharmaceuticals Co., Ltd 140
Testing effectiveness (Phase 2)Looking for participantsNCT03907475What this trial is testingDurvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ TrialWho this might be right forLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm National Cancer Institute (NCI) 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128What this trial is testingSelpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Who this might be right forNon-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more Eli Lilly and Company 857
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053What this trial is testingRare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Who this might be right forRare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Early research (Phase 1)Ended earlyNCT05859464What this trial is testingZL-1218 in Subjects With Advanced Solid TumorsWho this might be right forMalignant Solid Tumor Zai Lab (Hong Kong), Ltd. 34
Testing effectiveness (Phase 2)Study completedNCT01515306What this trial is testingRamucirumab (IMC-1121B) and Paclitaxel in Participants With Solid TumorsWho this might be right forMalignant Solid Tumor Eli Lilly and Company 48
Early research (Phase 1)Study completedNCT05501821What this trial is testingStudy of KBA1412 in Participants With Advanced Solid Malignant TumorsWho this might be right forAdvanced Solid Tumor Malignancy Kling Biotherapeutics B.V. 16
Early research (Phase 1)Study completedNCT01193595What this trial is testingDose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsWho this might be right forNeoplasms, Malignant Sanofi 39